Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. - Janson,C.; McPhee,S.; Bilaniuk,L.; Haselgrove,J.; Testaiuti,M.; Freese,A. (Hum Gene Ther, 2002)